These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2015034)

  • 1. [Epidemiologic study of anti-HTLV-I/II antibodies in blood donors in metropolitan France. The Retrovirus Working Group of the National Blood Transfusion Society].
    Lemaire JM; Coste J; Barin F; Couroucé AM
    Rev Fr Transfus Hemobiol; 1991 Jan; 34(1):21-34. PubMed ID: 2015034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.
    Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH
    BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of enzyme immunoassays for antibody to human T-lymphotropic viruses type I/II.
    Kline RL; Brothers T; Halsey N; Boulos R; Lairmore MD; Quinn TC
    Lancet; 1991 Jan; 337(8732):30-3. PubMed ID: 1670658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of HTLV-I/II in universal screening of blood donations in France.
    Couroucé AM; Pillonel J; Lemaire JM; Maniez M; Brunet JB
    AIDS; 1993 Jun; 7(6):841-7. PubMed ID: 8103342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires.
    Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA
    Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of commercial equipment used in blood banks in Córdoba for the detection of anti-HTLV-I/II antibodies].
    Llop N; Gastaldello R; Valle M; Macedo R; Maturano E; Blanco S; Medeot S; Gallego S
    Rev Argent Microbiol; 2000; 32(4):202-5. PubMed ID: 11149153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors.
    Anderson DW; Epstein JS; Lee TH; Lairmore MD; Saxinger C; Kalyanaraman VS; Slamon D; Parks W; Poiesz BJ; Pierik LT
    Blood; 1989 Nov; 74(7):2585-91. PubMed ID: 2804381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic comparison of human T-lymphotropic virus type I-infected blood donors from endemic and nonendemic regions over a 3-year period.
    Massari V; Elghouzzi MH; Agis F; Rannou C; Gordien E; Costagliola D; Lefrère JJ
    Transfusion; 1994 Mar; 34(3):198-201. PubMed ID: 8146890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HTLV-I/II antibodies in French blood donors.
    Coste J; Lemaire JM; Barin F; Courouce AM
    Lancet; 1990 May; 335(8698):1167-8. PubMed ID: 1971905
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitivity and specificity of four assays to detect human T-lymphotropic virus type I or type I/II antibodies.
    Vrielink H; Reesink HW; Zaaijer HL; van der Poel CL; Cuypers HT; Lelie PN
    Transfusion; 1996 Apr; 36(4):344-6. PubMed ID: 8623137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-transmitted HTLV-I/II infection in patients undergoing open-heart surgery.
    Shih JW; Lee HH; Falchek M; Canavaggio M; Jett BW; Allain JP; Alter HJ
    Blood; 1990 Feb; 75(3):546-9. PubMed ID: 2297566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to HTLV-I p24 in sera of blood donors, elderly people and patients with hemopoietic diseases in France and in French West Indies.
    Schaffar-Deshayes L; Chavance M; Monplaisir N; Courouce AM; Gessain A; Blesonski S; Valette I; Feingold N; Levy JP
    Int J Cancer; 1984 Nov; 34(5):667-70. PubMed ID: 6094365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of antibody to human T-cell lymphotropic virus type I/II in people of Caribbean origin in Toronto.
    Chiavetta J; Nusbacher J; Tam F; Wall A; Steaffens J; Lee H
    CMAJ; 1992 Nov; 147(10):1493-8. PubMed ID: 1423089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil.
    Ferreira Júnior OC; Vaz RS; Carvalho MB; Guerra C; Fabron AL; Rosemblit J; Hamerschlak N
    Transfusion; 1995 Mar; 35(3):258-63. PubMed ID: 7878720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic variations of retrovirus in Japanese cancer patients.
    Maruyama K; Miyauchi M; Fukushima T; Mochizuki S; Koshikawa N; Kawamura K; Tamayama C; Nakano M; Odo A; Iha S
    Leukemia; 1989 Apr; 3(4):277-81. PubMed ID: 2927177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.